According to our (Global Info Research) latest study, the global Single Use Blood Bag market size was valued at US$ 535 million in 2025 and is forecast to a readjusted size of US$ 749 million by 2032 with a CAGR of 4.9% during review period.
Disposable Blood Bag is used for the collection, storage, processing, transport, separation and transfusion of Blood Banks and Hospitals, including FFP Blood Bags. There are such types for single blood bag, double blood bag, triple blood bag, quadruple blood bag, etc. The volume varies from 150 ml to 400 ml.
Key Findings
Global volume reached 198.77 million units in 2025
North America held 34.59% of 2025 market revenue
Triple blood bags represented 49.96% of 2025 revenue
Blood stations accounted for 76.04% of 2025 revenue
Top five suppliers represented approximately 73.1% of 2025 revenue
Market Trends
The Single Use Blood Bag industry is moving from basic blood collection toward integrated blood-component preparation systems. Triple and quadruple blood bags have become the core product structures as blood centers increasingly separate whole blood into red blood cells, plasma, platelets and other components, while integrated leukocyte-reduction, additive-solution and closed-transfer functions are raising the functional value of each system. At the same time, product development is increasingly influenced by material safety, automation compatibility and traceability requirements. PVC remains the mainstream material, but demand for alternative plasticizer solutions is increasing; meanwhile, compatibility with automated blood-component processing equipment, digital identification and blood-center information systems is becoming more important. This transition is gradually shifting competition from basic bag manufacturing toward integrated performance across materials, filtration, fluid-path design, automation compatibility and process reliability.
Market Dynamics
Drivers
Demand for Single Use Blood Bag is fundamentally supported by the recurring need for blood collection, component preparation and transfusion in surgery, trauma care, oncology, obstetrics, hematology and other clinical settings. The continued shift from whole-blood transfusion toward component therapy strengthens demand for multi-bag systems because one donation can be processed into several clinically usable components. Expansion and modernization of blood-service infrastructure in emerging markets also support unit demand, while stricter blood-safety requirements create additional value for higher-specification systems with closed processing, leukocyte reduction and improved storage functionality.
Restraints
The principal restraint is pricing pressure in standardized blood bag categories. Basic single, double, triple and quadruple systems are mature products, and centralized procurement or tender-based purchasing can limit manufacturers’ pricing flexibility. Medical-grade PVC film, tubing, needles, ports, anticoagulant solutions and sterilization collectively create a cost base that cannot be reduced without affecting product consistency or regulatory compliance. Material transitions also require extensive validation because changes in plasticizers or polymer formulations may affect blood-cell preservation, flexibility, sterilization compatibility and shelf life, slowing rapid substitution of established material systems.
Opportunities
The most attractive opportunities are concentrated in higher-value blood-component processing systems and emerging blood-service markets. Rising penetration of triple, quadruple and specialized multi-bag configurations creates room for products integrating leukocyte filters, additive solutions, sampling devices and safer closed transfer pathways. China, India, Southeast Asia and other developing blood-service markets are expected to contribute an increasing share of incremental demand as collection infrastructure and component-processing capabilities expand. Manufacturers capable of combining scale manufacturing with advanced filtration, material engineering and compatibility with automated blood-processing platforms are positioned to capture a larger portion of this structural upgrade.
Challenges
Long-term industry challenges center on regulatory complexity, quality consistency and customer concentration. Single Use Blood Bag directly contacts and stores human blood, requiring strict control of biocompatibility, sterility, seal integrity, anticoagulant filling, tubing connections and batch traceability. Qualification by major blood centers can involve prolonged validation and supplier assessment, while different regulatory requirements across regions increase registration and compliance costs. At the commercial level, large blood centers and public procurement systems can represent substantial portions of supplier demand, making tender cycles, pricing changes and customer switching meaningful risks for individual manufacturers.
Industry Chain Analysis
The Single Use Blood Bag industry chain begins with medical-grade polymer film, plasticizers, tubing materials, medical needles, molded connectors, ports, anticoagulant chemicals, additive solutions, packaging materials and filtration media. Midstream manufacturing combines film forming or sourcing, cutting, radio-frequency welding, tubing and component assembly, anticoagulant or additive-solution filling, sealing, integrity testing, sterilization and final packaging. As the number of connected bags increases, manufacturing complexity rises because additional tubing connections, satellite bags, solution chambers and optional leukocyte filters introduce more welding points and quality-control requirements.
Downstream value is concentrated in blood stations, blood centers and hospital transfusion systems. Blood stations represent the principal purchasing base because they undertake whole-blood collection and component preparation at scale, while hospitals primarily consume transfer, storage and specialty blood bag products and manage clinical transfusion-related workflows. Product value is therefore created not only through bag manufacturing but through validated blood compatibility, sterile system integrity, component-processing efficiency, storage performance and repeatable supply quality. This explains why qualification, regulatory compliance and long-term supply capability remain important competitive barriers even in relatively mature product categories.
Segment Insights
Triple blood bags are the largest product segment by revenue, representing approximately half of the market in 2025, while quadruple blood bags account for more than two-fifths. Together, these two categories dominate market value because they are widely used for component preparation and carry higher average selling prices than simpler single and double configurations. In 2025, the study estimates average prices of approximately USD 2.67 per set for triple bags and USD 2.92 per set for quadruple bags, compared with below USD 1 per set for single bags.
The product mix is expected to continue shifting toward more functional multi-bag systems. Triple bags are projected to gain further volume share through 2032, while quadruple bags remain a major segment supported by advanced component preparation. The main commercial opportunity is therefore not simply higher bag counts but higher-value configurations incorporating additive solutions, filtration, safer sampling, optimized tubing pathways and compatibility with automated processing systems.
Downstream Market Opportunities
Blood stations remain the central downstream market for Single Use Blood Bag, accounting for roughly three-quarters of global revenue in 2025. Their demand is driven by large-scale collection, separation, transfer and storage workflows, giving them higher consumption intensity than hospitals. Hospitals represent a smaller but stable opportunity centered on transfusion departments, hospital blood banks, emergency care, surgery, autologous blood management and specialized transfer or storage applications. Future downstream opportunities will increasingly favor products that improve workflow efficiency, support standardized component preparation and reduce contamination or handling risk rather than simply providing basic blood containment.
Regional Insights
North America is the largest regional revenue market, accounting for approximately 34.6% of global revenue in 2025, followed by Europe at about 27.4%. These mature markets combine established blood-service systems with higher adoption of advanced component-processing, leukocyte-reduction and higher-specification blood bag configurations, supporting revenue shares that exceed their corresponding volume shares. China represented approximately 12.0% of global revenue in 2025, with the market measured at USD 62.44 million, and is projected to reach USD 101.59 million by 2032, reflecting stronger structural expansion than the mature North American and European markets.
From a volume perspective, emerging markets are becoming increasingly important. China’s share of global unit sales is projected to rise from about 15.2% in 2025 to approximately 17.0% in 2032, while India and Southeast Asia also gain share. The regional opportunity is therefore differentiated: mature markets offer higher-value replacement and product-upgrade demand, whereas emerging markets provide stronger opportunities from expanding collection coverage, component-processing capacity and localized manufacturing.
Competitive Landscape Analysis
The Single Use Blood Bag market is relatively concentrated, with the five largest suppliers accounting for approximately 73.1% of 2025 revenue. Fresenius remains the largest supplier in the study, followed by Terumo, WEGO, GVS Filter Technology and JMS, while SB-KAWASUMI, Nigale Biomedical, Macopharma and other regional suppliers maintain meaningful positions in specific geographic or product niches. Competitive differentiation reflects more than production scale: international suppliers generally emphasize established blood-center relationships, higher-specification systems, filtration and processing technologies, while Chinese and Indian manufacturers increasingly compete through manufacturing scale, cost efficiency, broad configurations and export expansion. As blood centers adopt more automated and standardized workflows, suppliers able to integrate blood bags with filtration, processing equipment, data systems and validated consumable ecosystems are likely to strengthen customer retention and recurring demand.
Report Scope
This report is a detailed and comprehensive analysis for global Single Use Blood Bag market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Single Use Blood Bag market size and forecasts, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2021-2032
Global Single Use Blood Bag market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2021-2032
Global Single Use Blood Bag market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2021-2032
Global Single Use Blood Bag market shares of main players, shipments in revenue ($ Million), sales quantity (M Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Single Use Blood Bag
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Single Use Blood Bag market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Fresenius, JMS, Terumo, Weigao Group, Nanger Biomedical, Beijing Bodesante, Macopharma, Poly Medicure, GVS Filter Technology, SB-KAWASUMI, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Single Use Blood Bag market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market Segmentation
Market segment by Type
Single Blood Bag
Double Blood Bag
Triple Blood Bag
Quadruple Blood Bag
Other
Market segment by Function
Standard Blood Bag
Leukocyte-reduction Blood Bag
Market segment by Blood Collection Type
Whole Blood Collection Bag
Blood Component Processing Bag
Blood Transfer and Storage Bag
Special-purpose Blood Bag
Market segment by Application
Blood Bank
Hospital
Major players covered
Fresenius
JMS
Terumo
Weigao Group
Nanger Biomedical
Beijing Bodesante
Macopharma
Poly Medicure
GVS Filter Technology
SB-KAWASUMI
Mitra Industries
Sichuan Mianzhu Hongji Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter Outline
Chapter 1, to describe Single Use Blood Bag product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Single Use Blood Bag, with price, sales quantity, revenue, and global market share of Single Use Blood Bag from 2021 to 2026.
Chapter 3, the Single Use Blood Bag competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Single Use Blood Bag breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Single Use Blood Bag market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Single Use Blood Bag.
Chapter 14 and 15, to describe Single Use Blood Bag sales channel, distributors, customers, research findings and conclusion.
Summary:
Get latest Market Research Reports on Single Use Blood Bag. Industry analysis & Market Report on Single Use Blood Bag is a syndicated market report, published as Global Single Use Blood Bag Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Single Use Blood Bag market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.